Clinical research firm Science 37, Inc. will relocate its corporate headquarters to Morrisville, North Carolina. The project is expected to create 250 jobs over five years in Wake County.

According to state officials, the company will transition its headquarters from Culver City, California.

“The Science 37 model has enabled clinical trial sponsors to accelerate enrollment, retain patients longer and attract a more representative patient population, which has led to tremendous growth for our company,” said David Coman, CEO of Science 37. “Establishing our headquarters in the Research Triangle, a magnet for biopharmaceutical innovation, will enable Science 37 to continue grow; attracting and retaining top talent dedicated to accelerating research and enabling access for patients and providers, anywhere.”

Science 37’s project in North Carolina will be facilitated by a Job Development Investment Grant (JDIG) approved by the state’s Economic Investment Committee. Over the course of the 12-year term of this grant, the project is estimated to grow the state’s economy by $783 million. Using a formula that takes into account the new tax revenues generated by the new jobs, the JDIG agreement authorizes the potential reimbursement to the company of up to $3,336,750, spread over 12 years.

State payments only occur following performance verification by the departments of Commerce and Revenue that the company has met its incremental job creation and investment targets. JDIG projects result in positive net tax revenue to the state treasury, even after taking into consideration the grant’s reimbursement payments to a given company.

"I’m pleased to welcome Science 37’s new headquarters to North Carolina and the Research Triangle,” said Governor Roy Cooper. “With our talented workforce and strong infrastructure, North Carolina offers the right ingredients for life science companies and their employees to succeed.”

Science 37's mission is to enable universal access to clinical research, making it easier for patients and providers to participate from anywhere. As a pioneer of decentralized clinical trials, the company’s Clinical Trial Operating System (OS) supports today’s more agile clinical research designs with its full stack, end-to-end technology platform and specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators and connected devices.

“The ecosystem that supports North Carolina’s life science industry is second to none, and Science 37’s decision strengthens our position even more,” said North Carolina Commerce Secretary Machelle Baker Sanders. “Companies in this vibrant industry depend on our skilled and talented workforce, and as the state’s First in Talent strategic plan makes clear, investments in our educational and training systems will keep opportunities like this coming our way.”

Partnering with the North Carolina Department of Commerce and the Economic Development Partnership of North Carolina (EDPNC) on this project were the North Carolina General Assembly, the North Carolina Community College System, the North Carolina Biotechnology Center, the Capital Area Workforce Development Board, Wake Tech Community College, Wake County, the Town of Morrisville, the Morrisville Chamber of Commerce and Wake County Economic Development, a program of the Raleigh Chamber.